The Cystic Fibrosis Foundation spearheads groundbreaking research initiatives aimed at uncovering innovative therapies to combat cystic fibrosis (CF). With a steadfast commitment to advancing medical science, we support a diverse array of research programs designed to discover and develop effective treatments for CF. Central to our research efforts are clinical trials, which serve as pivotal stages in evaluating the safety and efficacy of promising drugs and therapies. These trials are conducted at Foundation-accredited care centers across the United States, ensuring access to cutting-edge treatments for individuals affected by CF nationwide. Moreover, our comprehensive drug development pipeline provides a transparent overview of the progress made in the quest for new therapies, offering valuable insights to both participants and stakeholders alike, regardless of their involvement in clinical trials. Through our relentless pursuit of scientific innovation, we remain steadfast in our mission to improve the lives of those impacted by CF and to forge a path toward a future free from the constraints of this complex disease.